Agilent Technologies and Stemina Biomarker Discovery have announced that Agilent will be providing a liquid chromatography system and quadrupole time-of-flight mass spectrometer to accelerate Stemina's metobolomic research.
Agilent Technologies and Stemina Biomarker Discovery have announced that Agilent will be providing a liquid chromatography system and quadrupole time-of-flight mass spectrometer to accelerate Stemina's metobolomic research. The research team uses metabolomic analysis of stem cells for the discovery of biomarkers for use in drug screening and drug development. Software will also be supplied to help researchers interpret the complex data generated by metabolomics experiments.
"We are pleased to broaden our relationship with Agilent to advance our scientific platform and our discovery of important small molecules involved in developmental toxicity and autism," said Beth Donley, Stemina CEO.
"Metabolomics is a major growth area for us, and the innovative work being done at Stemina is the kind we like to support," said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. "We've aggressively built an LC–MS portfolio for the life sciences in recent years, and the software provides the crucial ability to visualize biological pathways from the massive and complex data sets generated by metabolomics studies."
For more information on the research company visit www.stemina.com
More information on the products is available at www.agilent.com
Fundamentals of Benchtop GC–MS Data Analysis and Terminology
April 5th 2025In this installment, we will review the fundamental terminology and data analysis principles in benchtop GC–MS. We will compare the three modes of analysis—full scan, extracted ion chromatograms, and selected ion monitoring—and see how each is used for quantitative and quantitative analysis.
Characterizing Plant Polysaccharides Using Size-Exclusion Chromatography
April 4th 2025With green chemistry becoming more standardized, Leena Pitkänen of Aalto University analyzed how useful size-exclusion chromatography (SEC) and asymmetric flow field-flow fractionation (AF4) could be in characterizing plant polysaccharides.
This information is supplementary to the article “Accelerating Monoclonal Antibody Quality Control: The Role of LC–MS in Upstream Bioprocessing”, which was published in the May 2025 issue of Current Trends in Mass Spectrometry.